Ace Report Cover
IV and topical TXA superior to placebo for hematological outcomes after PLIF
Reprints
Cite This
Reprints
Cite This
AceReport Image
Spine
IV and topical TXA superior to placebo for hematological outcomes after PLIF
World Neurosurg. 2019 Feb;122:e821-e827.
Contributing Authors

J Wei Z Li C Wang X Mu Y Ou D Yin B Liang D Qiu

150 patients with lumbar degenerative disease and scheduled for a posterior lumbar interbody fusion procedure were randomized to receive intravenous TXA, topical TXA or placebo for blood loss. Outcomes of interest included hemoglobin, hematocrit and fibrinogen levels, prothrombin time, extubation time, hospital length of stay, post-operative Visual Analog Scale (VAS), intra-operative blood loss, drainage volume, visible and hidden blood loss volume, and post-operative blood transfusion. The study results displayed significantly favourable outcomes in the IV and topical TXA groups compared to the control group in hemoglobin and hematocrit levels, extubation time, hospital length of stay, intra-operative blood loss, drainage volume, visible and hidden blood loss, and blood transfusion. Moreover, the IV TXA group outperformed the topical TXA group in hemoglobin and hematocrit levels, intra-operative blood loss, as well as visible and hidden blood loss.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. IV and topical TXA superior to placebo for hematological outcomes after PLIF. ACE Report. 2019;9(4):36. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report